Thulium laser
News
14.03.2016
Merck Initiates Phase III Study of MSB11022
Merck, a leading science and technology company, today announced the initiation of a global Phase III clinical study of MSB11022, a proposed biosimilar of adalimumab, in chronic plaque psoriasis. This […]
11.03.2016
VICHY Announces the First Annual VICHY EXPOSOME GRANT
VICHY Laboratoires, the VICHY EXPOSOME GRANT will promote and encourage research activity on the skin exposome. One research grant of 15 000 € will be awarded annually to a research […]
19.01.2016
Vitiligo & Pigmentary Disorders Masterclass Tel Aviv, November 25 – 26, 2015
It was a great pleasure to be invited by Dr. Ines Verner to take part in the above mentioned Masterclass in Tel Aviv. On behalf of the Israel Society of […]
